Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model
Kyle Rosenke, Frederick Hansen, Benjamin Schwarz, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 147

Showing 26-50 of 147 citing articles:

COVID-19 therapeutics
Daniele Focosi, Massimo Franchini, Fabrizio Maggi, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 10
Decoding molnupiravir-induced mutagenesis in SARS-CoV-2
Luis Menéndez‐Arias
Journal of Biological Chemistry (2021) Vol. 297, Iss. 1, pp. 100867-100867
Open Access | Times Cited: 51
New Perspectives on Antimicrobial Agents: Molnupiravir and Nirmatrelvir/Ritonavir for Treatment of COVID-19
Robert L. Atmar, Natalie Finch
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 8
Open Access | Times Cited: 34
Antiviral therapy for COVID-19: Derivation of optimal strategy based on past antiviral and favipiravir experiences
Kimiyasu Shiraki, Noriaki Sato, Kaoru Sakai, et al.
Pharmacology & Therapeutics (2022) Vol. 235, pp. 108121-108121
Open Access | Times Cited: 30
Combined molnupiravir-nirmatrelvir treatment improves the inhibitory effect on SARS-CoV-2 in macaques
Kyle Rosenke, Matt C. Lewis, Friederike Feldmann, et al.
JCI Insight (2022) Vol. 8, Iss. 4
Open Access | Times Cited: 30
Heat shock protein 90 facilitates SARS-CoV-2 structural protein-mediated virion assembly and promotes virus-induced pyroptosis
Zhuangzhuang Zhao, Ling-Dong Xu, Fei Zhang, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 5, pp. 104668-104668
Open Access | Times Cited: 17
A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes
Theo Sanderson, Ryan Hisner, I’ah Donovan-Banfield, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 16
Evaluation of In Vitro Distribution and Plasma Protein Binding of Selected Antiviral Drugs (Favipiravir, Molnupiravir and Imatinib) against SARS-CoV-2
Orsolya Dömötör, Éva A. Enyedy
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2849-2849
Open Access | Times Cited: 15
Transcriptional regulation of SARS-CoV-2 receptor ACE2 by SP1
Hui Han, Rong‐Hua Luo, Xin‐Yan Long, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 5
The Wnt/β-catenin pathway is important for replication of SARS-CoV-2 and other pathogenic RNA viruses
Zaikun Xu, Mohamed Elaish, Cheung Pang Wong, et al.
npj Viruses (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 5
Scaling Factors to inform In Vitro-In Vivo Extrapolation from Preclinical and Livestock Animals: State of the Field and Recommendations for Development of Missing Data
A. Zimmer, Abby C. Collier
Drug Metabolism Reviews (2025), pp. 1-52
Closed Access
Review on the current status of Syrian hamsters as an animal model for COVID-19 transmission, pathogenesis, treatment and vaccine research
Biruh Mebratu Belay, Abebe Tesfaye Gessese, Mebrie Zemene Kinde, et al.
All Life (2025) Vol. 18, Iss. 1
Open Access
Mechanisms of Lung Injury Induced by SARS-CoV-2 Infection
Samsara Upadhya, Jalees Rehman, Asrar B. Malik, et al.
Physiology (2021) Vol. 37, Iss. 2, pp. 88-100
Open Access | Times Cited: 36
Treatments for COVID-19: Lessons from 2020 and new therapeutic options
Fanny Salasc, Thomas Lahlali, Emilie Laurent, et al.
Current Opinion in Pharmacology (2021) Vol. 62, pp. 43-59
Open Access | Times Cited: 32
Efficacy and safety of Molnupiravir in COVID-19 patients: a systematic review
Kalpana Mali, Madhavi Eerike, Gerard Marshall Raj, et al.
Irish Journal of Medical Science (1971 -) (2022) Vol. 192, Iss. 4, pp. 1665-1678
Open Access | Times Cited: 26
Inhibitors of dihydroorotate dehydrogenase cooperate with molnupiravir and N4-hydroxycytidine to suppress SARS-CoV-2 replication
Kim M. Stegmann, Antje Dickmanns, Natalie Heinen, et al.
iScience (2022) Vol. 25, Iss. 5, pp. 104293-104293
Open Access | Times Cited: 25
A Comprehensive Review on the Efficacy of Several Pharmacologic Agents for the Treatment of COVID-19
Fatma Haddad, Ghadeer Dokmak, Rafik Karaman
Life (2022) Vol. 12, Iss. 11, pp. 1758-1758
Open Access | Times Cited: 22
Development and validation of molnupiravir assessment in bulk powder and pharmaceutical formulation by the RP-HPLC-UV method
Abdelaziz M. Annadi, Noha M. El Zahar, Nour E. A. Abd El‐Sattar, et al.
RSC Advances (2022) Vol. 12, Iss. 53, pp. 34512-34519
Open Access | Times Cited: 22
COVID drug drives viral mutations — and now some want to halt its use
Ewen Callaway
Nature (2023) Vol. 614, Iss. 7948, pp. 399-399
Closed Access | Times Cited: 14
The Antiviral Effect of Nirmatrelvir/Ritonavir during COVID-19 Pandemic Real-World Data
Vasileios Petrakis, Petros I. Rafailidis, Grigorios Trypsianis, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 976-976
Open Access | Times Cited: 14
Computational studies of closely related 2-cyanopyrimidine, pyrimidine-2-carboximidamide and 2,4,6-tris(2-pyrimidyl)-1,3,5-triazine with a potency against SARS-CoV-2
Tuğba Taşkın‐Tok, Damir A. Safin
Monatshefte für Chemie - Chemical Monthly (2023) Vol. 155, Iss. 1, pp. 57-71
Open Access | Times Cited: 13
Favipiravir and Ribavirin protect immunocompetent mice from lethal CCHFV infection
Thomas Tipih, Kimberly Meade‐White, Deepashri Rao, et al.
Antiviral Research (2023) Vol. 218, pp. 105703-105703
Open Access | Times Cited: 12
Preparation and Characterization of Fe-Gallic acid MOF for determination of antiviral Molnupiravir as inhibitor for RNA Corona virus replication
Huda M. Younis, Ahmed O. Youssef, Said M. El‐Sheikh, et al.
Microchemical Journal (2023) Vol. 194, pp. 109297-109297
Closed Access | Times Cited: 12
Coronavirus Disease 2019: Clinics, Treatment, and Prevention
Francesco Burkert, Lukas Lanser, Rosa Bellmann‐Weiler, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 28
Progress and pitfalls of a year of drug repurposing screens against COVID-19
Julien Sourimant, Megha Aggarwal, Richard K. Plemper
Current Opinion in Virology (2021) Vol. 49, pp. 183-193
Open Access | Times Cited: 27

Scroll to top